Suchergebnisse - "Abbott, Frederick M."

PubPharm (50)

1

Prosecuting Excessive Pricing of Pharmaceuticals under Competition Law : Evolutionary Development

Erschienen: [S.l.], SSRN, 2023

von Abbott, F.

2

Excessive Pricing Doctrine in the Pharmaceutical Sector : The Space for Reform

Erschienen: [S.l.], SSRN, [2022]

EU Competition Law and Pharmaceuticals, W. Sauter, M. Canoy and J. Mulder (eds), Edward Elgar, 2022 (Dec. 16, 2021 rev)

von Abbott, F.

3

Opportunities, Constraints and Critical Supports for Achieving Sustainable Local Pharmaceutical Manufacturing in Africa : With a Focus on the Role of Finance, Final Report

Erschienen: [S.l.], SSRN, [2021]

Nova Worldwide (2021)

von Abbott, F. | Abbott, R. | Fortunak, J. | +2

4

Facilitating access to cross-border supplies of patented pharmaceuticals : the case of the COVID-19 pandemic

enthalten in: Journal of international economic law | 2020

von Abbott, F. | Reichman, J.

5

Chapter : Health and Intellectual Property

Erschienen: [S.l.], SSRN, [2018]

von Abbott, F.

6

The Generics Pathway in the USA : The American Experience, a Model for the World?

Erschienen: [S.l.], SSRN, [2018]

von Abbott, F.

7

Reflections on the Report of the UN Secretary General's High Level Panel on Access to Medicines

enthalten in: Ciencia & saude coletiva | 2017

von Abbott, F.

CommentOn: Cien Saude Colet. 2017 Aug;22(8):2435-2439. - PMID 28793061

8

China Policies to Promote Local Production of Pharmaceutical Products and Protect Public Health

Erschienen: [S.l.], SSRN, [2017]

von Abbott, F.

9

Indian Policies to Promote Local Production of Pharmaceutical Products and Protect Public Health

Erschienen: [S.l.], SSRN, [2017]

von Abbott, F.

10

Excessive Pharmaceutical Prices and Competition Law : Doctrinal Development to Protect Public Health

Erschienen: [S.l.], SSRN, [2017]

von Abbott, F.

1
2
3
4
5
Nächster »
[5]